Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions

Aleksandra Korniluk, Olga Martyna Koper-Lenkiewicz, Joanna Kamińska, Halina Kemona, Violetta Dymicka-Piekarska, Aleksandra Korniluk, Olga Martyna Koper-Lenkiewicz, Joanna Kamińska, Halina Kemona, Violetta Dymicka-Piekarska

Abstract

Platelet size has been demonstrated to reflect platelet activity and seems to be a useful predictive and prognostic biomarker of cardiovascular events. It is associated with a variety of prothrombotic and proinflammatory diseases. The aim is a review of literature reports concerning changes in the mean platelet volume (MPV) and its possible role as a biomarker in inflammatory processes and neoplastic diseases. PubMed database was searched for sources using the following keywords: platelet activation, platelet count, mean platelet volume and: inflammation, cancer/tumor, cardiovascular diseases, myocardial infarction, diabetes, lupus disease, rheumatoid arthritis, tuberculosis, ulcerative colitis, renal disease, pulmonary disease, influencing factors, age, gender, genetic factors, oral contraceptives, smoking, lifestyle, methods, standardization, and hematological analyzer. Preference was given to the sources which were published within the past 20 years. Increased MPV was observed in cardiovascular diseases, cerebral stroke, respiratory diseases, chronic renal failure, intestine diseases, rheumatoid diseases, diabetes, and various cancers. Decreased MPV was noted in tuberculosis during disease exacerbation, ulcerative colitis, SLE in adult, and different neoplastic diseases. The study of MPV can provide important information on the course and prognosis in many inflammatory conditions. Therefore, from the clinical point of view, it would be interesting to establish an MPV cut-off value indicating the intensity of inflammatory process, presence of the disease, increased risk of disease development, increased risk of thrombotic complications, increased risk of death, and patient's response on applied treatment. Nevertheless, this aspect of MPV evaluation allowing its use in clinical practice is limited and requires further studies.

Figures

Figure 1
Figure 1

References

    1. Linke B., Schreiber Y., Picard-Willems B., et al. Activated platelets induce an anti-inflammatory response of monocytes/macrophages through cross-regulation of PGE2 and cytokines. Mediators of Inflammation. 2017;2017:14. doi: 10.1155/2017/1463216.1463216
    1. Endler G., Klimesch A., Sunder-Plassmann H., et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. British Journal of Haematology. 2002;117(2):399–404. doi: 10.1046/j.1365-2141.2002.03441.x.
    1. Slavka G., Perkmann T., Haslacher H., et al. Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2011;31(5):1215–1218. doi: 10.1161/ATVBAHA.110.221788.
    1. Huczek Z., Kochman J., Filipiak K. J., et al. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. Journal of the American College of Cardiology. 2005;46(2):284–290. doi: 10.1016/j.jacc.2005.03.065.
    1. Shah B., Oberweis B., Tummala L., et al. Mean platelet volume and long-term mortality in patients undergoing percutaneous coronary intervention. American Journal of Cardiology. 2013;111(2):185–189. doi: 10.1016/j.amjcard.2012.09.014.
    1. D'Erasmo E., Aliberti G., Celi F. S., Romagnoli E., Vecci E., Mazzuoli G. F. Platelet count, mean platelet volume and their relation to prognosis in cerebral infarction. Journal of Internal Medicine. 1990;227(1):11–14. doi: 10.1111/j.1365-2796.1990.tb00111.x.
    1. Greisenegger S., Endler G., Hsieh K., Tentschert S., Mannhalter C., Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke. 2004;35(7):1688–1691. doi: 10.1161/01.STR.0000130512.81212.a2.
    1. O’Malley T., Langhorne P., Elton R. A., Stewart C. Platelet size in stroke patients. Stroke. 1995;26(6):995–999. doi: 10.1161/01.STR.26.6.995.
    1. Feng Y., Yin H., Mai G., et al. Elevated serum levels of CCL17 correlate with increased peripheral blood platelet count in patients with active tuberculosis in China. Clinical and Vaccine Immunology. 2011;18(4):629–632. doi: 10.1128/CVI.00493-10.
    1. Unsal E., Aksaray S., Köksal D., Sipit T. Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis. Postgraduate Medical Journal. 2005;81(959):604–607. doi: 10.1136/pgmj.2004.030544.
    1. Koç S., Eyibilen A., Erdoğan A. S. Mean platelet volume as an inflammatory marker in chronic sinusitis. European Journal of General Medicine. 2011;8(4):314–317. doi: 10.29333/ejgm/82761.
    1. Sharpe P. C., Desai Z. R., Morris T. C. Increase in mean platelet volume in patients with chronic renal failure treated with erythropoietin. Journal of Clinical Pathology. 1994;47(2):159–161. doi: 10.1136/jcp.47.2.159.
    1. Liu S., Ren J., Han G., et al. Mean platelet volume: a controversial marker of disease activity in Crohn’s disease. European Journal of Medical Research. 2012;17(1):p. 27. doi: 10.1186/2047-783X-17-27.
    1. Zubcevic N., Mesihovic R., Zubcevic S. Usefulness of laboratory data in estimation of Crohn’s disease activity. Medical Archives. 2010;64(1):33–36.
    1. Gasparyan A. Y., Sandoo A., Stavropoulos-Kalinoglou A., Kitas G. D. Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-α therapy. Rheumatology International. 2010;30(8):1125–1129. doi: 10.1007/s00296-009-1345-1.
    1. Yavuz S., Ece A. Mean platelet volume as an indicator of disease activity in juvenile SLE. Clinical Rheumatology. 2014;33(5):637–641. doi: 10.1007/s10067-014-2540-3.
    1. Papanas N., Symeonidis G., Maltezos E., et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2009;15(8):475–478. doi: 10.1080/0953710042000267707.
    1. Rollini F., Franchi F., Muñiz-Lozano A., Angiolillo D. J. Platelet function profiles in patients with diabetes mellitus. Journal of Cardiovascular Translational Research. 2013;6(3):329–345. doi: 10.1007/s12265-013-9449-0.
    1. Kurt M., Onal I. K., Sayilir A. Y., et al. The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease. Hepato-Gastroenterology. 2012;59(117):1580–1582. doi: 10.5754/hge10444.
    1. Li N., Yu Z., Zhang X., et al. Elevated mean platelet volume predicts poor prognosis in colorectal cancer. Scientific Reports. 2017;7(1):p. 10261. doi: 10.1038/s41598-017-11053-y.
    1. Tunce T., Ozgun A., Emirzeoglu L., Celik S., Bilgi O., Karagoz B. Mean platelet volume as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab-combined chemotherapy. Asian Pacific Journal of Cancer Prevention. 2014;15(15):6421–6423. doi: 10.7314/APJCP.2014.15.15.6421.
    1. Kılınçalp S., Ekiz F., Başar Ö., et al. Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer. Platelets. 2013;25(8):592–594. doi: 10.3109/09537104.2013.783689.
    1. Matowicka-Karna J., Kamocki Z., Polińska B., Osada J., Kemona H. Platelets and inflammatory markers in patients with gastric cancer. Clinical and Developmental Immunology. 2013;2013:6. doi: 10.1155/2013/401623.401623
    1. Gong X., Zhang L., Yang D., et al. Mean platelet volume/platelet count ratio is associated with prognosis in patients with pancreatic cancer. International Journal of Clinical and Experimental Medicine. 2016;9(8):16379–16386.
    1. Yin J. B., Wang X., Zhang X., Liu L., Wang R. T. Mean platelet volume predicts survival in pancreatic cancer patients with synchronous liver metastases. Scientific Reports. 2018;8(1):p. 6014. doi: 10.1038/s41598-018-24539-0.
    1. Carlioglu A., Simsek E., Durmaz S. A., Ozmen H. K. Increased mean platelet volume in papillary thyroid cancer. Endocrine Abstracts. 2014;35 doi: 10.1530/endoabs.35.P1114.
    1. Gunluoglu G., Yazar E. E., Veske N. S., Seyhan E. C., Altin S. Mean platelet volume as an inflammation marker in active pulmonary tuberculosis. Multidisciplinary Respiratory Medicine. 2014;9(1):11–15. doi: 10.1186/2049-6958-9-11.
    1. Yuksel O., Helvaci K., Basar O., et al. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets. 2009;20(4):277–281. doi: 10.1080/09537100902856781.
    1. Delgado-García G., Galarza-Delgado D. Á., Colunga-Pedraza I., et al. Mean platelet volume is decreased in adults with active lupus disease. Revista Brasileira de Reumatologia. 2016;56(6):504–508. doi: 10.1016/j.rbre.2016.03.003.
    1. Inanc M., Duran A. O., Karaca H., et al. Haematologic parameters in metastatic colorectal cancer patients treated with capecitabine combination therapy. Asian Pacific Journal of Cancer Prevention. 2014;15(1):253–256. doi: 10.7314/APJCP.2014.15.1.253.
    1. Shen X.-M., Xia Y.-Y., Lian L., et al. Mean platelet volume provides beneficial diagnostic and prognostic information for patients with resectable gastric cancer. Oncology Letters. 2016;12(4):2501–2506. doi: 10.3892/ol.2016.4913.
    1. Karaman K., Bostanci E. B., Aksoy E., et al. The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas. European Journal of Internal Medicine. 2011;22(6):e95–e98. doi: 10.1016/j.ejim.2011.04.005.
    1. Yun Z. Y., Zhang X., Liu Y. S., et al. Lower mean platelet volume predicts poor prognosis in renal cell carcinoma. Scientific Reports. 2017;7(1):p. 6700. doi: 10.1038/s41598-017-07168-x.
    1. Inagaki N., Kibata K., Tamaki T., Shimizu T., Nomura S. Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer. Lung Cancer. 2014;83(1):97–101. doi: 10.1016/j.lungcan.2013.08.020.
    1. Kumagai S., Tokuno J., Ueda Y., et al. Prognostic significance of preoperative mean platelet volume in resected non-small-cell lung cancer. Molecular and Clinical Oncology. 2015;3(1):197–201. doi: 10.3892/mco.2014.436.
    1. Shen W. J., Fu S., Li N., et al. Decreased mean platelet volume is associated with cervical cancer development. Asian Pacific Journal of Cancer Prevention. 2017;18(7):1769–1772. doi: 10.22034/APJCP.2017.18.7.1769.
    1. Machlus K. R., Italiano J. E., Jr The incredible journey: from megakaryocyte development to platelet formation. The Journal of Cell Biology. 2013;201(6):785–796. doi: 10.1083/jcb.201304054.
    1. Zimmet J., Ravid K. Polyploidy: occurrence in nature, mechanisms, and significance for the megakaryocyte-platelet system. Experimental Hematology. 2000;28(1):3–16. doi: 10.1016/S0301-472X(99)00124-1.
    1. Patel S. R., Hartwig J. H., Italiano JE Jr The biogenesis of platelets from megakaryocyte proplatelets. Journal of Clinical Investigation. 2005;115(12):3348–3354. doi: 10.1172/JCI26891.
    1. Thon J. N., Macleod H., Begonja A. J., et al. Microtubule and cortical forces determine platelet size during vascular platelet production. Nature Communications. 2012;3(1) doi: 10.1038/ncomms1838.
    1. Kaushansky K. The molecular mechanisms that control thrombopoiesis. Journal of Clinical Investigation. 2005;115(12):3339–3347. doi: 10.1172/JCI26674.
    1. Gasparyan A. Y., Ayvazyan L., Mikhailidis D. P., Kitas G. D. Mean platelet volume: a link between thrombosis and inflammation? Current Pharmaceutical Design. 2011;17(1):47–58. doi: 10.2174/138161211795049804.
    1. Behnke O., Forer A. From megakaryocytes to platelets: platelet morphogenesis takes place in the bloodstream. European Journal of Haematology. 1998;61:3–23.
    1. Hartwig J., Italiano J. The birth of the platelet. Journal of Thrombosis and Haemostasis. 2003;1(7):1580–1586. doi: 10.1046/j.1538-7836.2003.00331.x.
    1. Barnard M. R., Krueger L. A., Frelinger A. L., III, Furman M. I., Michelson A. D. Whole blood analysis of leukocyte-platelet aggregates. Current Protocols in Cytometry. 2003 doi: 10.1002/0471142956.cy0615s24.
    1. Lopatina T., Bruno S., Tetta C., Kalinina N., Porta M., Camussi G. Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential. Cell Communication and Signaling: CCS. 2014;12(1):26–38. doi: 10.1186/1478-811X-12-26.
    1. Leblanc R., Peyruchaud O. Metastasis: new functional implications of platelets and megakaryocytes. Blood. 2016;128(1):24–31. doi: 10.1182/blood-2016-01-636399.
    1. Budak Y. U., Polat M., Huysal K. The use of platelet indices, plateletcrit, mean platelet volume and platelet distribution width in emergency non-traumatic abdominal surgery: a systematic review. Biochemical Medicine. 2016;26(2):178–193. doi: 10.11613/BM.2016.020.
    1. Sikora J., Kostka B. Blood platelets as pharmacological model. Postępy Biologii Komórki. 2005;3(32):561–569.
    1. Thompson C. B., Jakubowski J. A. The pathophysiology and clinical relevance of platelet heterogeneity. Blood. 1988;72(1):1–8.
    1. Panasiuk A. Płytki krwi w przewlekłych chorobach wątroby. Medical Science Review - Hepatologia. 2011;11:83–86. doi: 10.5604/17305039.970953.
    1. Ntolios P., Papanas N., Nena E., et al. Mean platelet volume as a surrogate marker for platelet activation in patients with idiopathic pulmonary fibrosis. Clinical and Applied Thrombosis/Hemostasis. 2015;22(4):346–350. doi: 10.1177/1076029615618023.
    1. Burstein S. A., Downs T., Friese P., et al. Thrombocytopoiesis in normal and sublethally irradiated dogs: response to human interleukin-6. Blood. 1992;80(2):420–428.
    1. Braekkan S. K., Mathiesen E. B., Njolstad I., Wilsgaard T., Stormer J., Hansen J. B. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø study. Journal of Thrombosis and Haemostasis. 2010;8(1):157–162. doi: 10.1111/j.1538-7836.2009.03498.x.
    1. Chu S. G., Becker R. C., Berger P. B., et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis. 2010;8(1):148–156. doi: 10.1111/j.1538-7836.2009.03584.x.
    1. Senchenkova E. Y., Komoto S., Russell J., et al. Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis. American Journal of Pathology. 2013;183(1):173–181. doi: 10.1016/j.ajpath.2013.03.014.
    1. Schwertz H., Koster S., Kahr W. H. A., et al. Anucleate platelets generate progeny. Blood. 2010;115(18):3801–3809. doi: 10.1182/blood-2009-08-239558.
    1. Kamath S., Blann A. D., Lip G. Y. Platelet activation: assessment and quantification. European Heart Journal. 2001;22(17):1561–1571. doi: 10.1053/euhj.2000.2515.
    1. Afsar N., Afroze I. A., Tahniath H., Abid Z. Role of mean platelet volume as an adjunct in evaluation of acute inflammation. Annals of Pathology and Laboratory Medicine. 2017;4(4):A466–A469. doi: 10.21276/apalm.1486.
    1. Elsenberg E. H. A. M., van Werkum J. W., van de Wal R. M. A., et al. The influence of clinical characteristics, laboratory and inflammatory markers on ‘high on-treatment platelet reactivity’ as measured with different platelet function tests. Thrombosis and Haemostasis. 2017;102(10):719–727. doi: 10.1160/TH09-05-0285.
    1. Gladwin A. M., Martin J. F. The control of megakaryocyte ploidy and platelet production: biology and pathology. International Journal of Cell Cloning. 1990;8(4):291–298. doi: 10.1002/stem.5530080414.
    1. Kario K., Matsuo T., Nakao K. Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clinical and Laboratory Haematology. 1992;14(4):281–287.
    1. Steinhubl S. R., Berger P. B., Mann III J. T., et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288(19):2411–2420. doi: 10.1001/jama.288.19.2411.
    1. Butterworth R. J., Bath P. M. The relationship between mean platelet volume, stroke subtype and clinical outcome. Platelets. 1998;9(6):359–364. doi: 10.1080/09537109876429.
    1. Eschbach J. W., Adamson J. W. Correction of the anaemia of haemodialysis (HD) patients with recombinant human erythropoietin: results of a multicenter study. Blood. 1987;70:p. 134a.
    1. Kapsoritakis A. N., Koukourakis M. I., Sfiridaki A., et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. The American Journal of Gastroenterology. 2001;96(3):776–781. doi: 10.1111/j.1572-0241.2001.03621.x.
    1. Kim D. A., Kim T. Y. Controversies over the interpretation of changes of mean platelet volume in rheumatoid arthritis. Platelets. 2011;22(1):79–80. doi: 10.3109/09537101003663758.
    1. Yazici S., Yazici M., Erer B., et al. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets. 2010;21(2):122–125. doi: 10.3109/09537100903474373.
    1. Şahin A., Yetişgin A., Şahin M., Durmaz Y., Cengiz A. K. Can mean platelet volume be a surrogate marker of inflammation in rheumatic diseases? West Indian Medical Journal. 2015;65(1):165–169. doi: 10.7727/wimj.2014.202.
    1. Moghimi J., Ghahremanfard F., Salari M., Ghorbani R. Association between mean platelet volume and severity of rheumatoid arthritis. Pan African Medical Journal. 2017;27 doi: 10.11604/pamj.2017.27.276.12228.
    1. El-Garf K., Marzouk H., Farag Y., Rasheed L., El-Garf A. Mean platelet volume is a marker of inflammation but not a marker of disease activity in children with juvenile SLE. The Egyptian Rheumatologist. 2016;38(1):35–39. doi: 10.1016/j.ejr.2015.06.002.
    1. Park B. J., Shim J. Y., Lee H. R., Jung D. H., Lee J. H., Lee Y. J. The relationship of platelet count mean platelet volume with metabolic syndrome according to the criteria of the American Association of Clinical Endocrinologists: a focus on gender differences. Platelets. 2011;23(1):45–50. doi: 10.3109/09537104.2011.589014.
    1. Sharpe P. C., Trinick T. Mean platelet volume in diabetes mellitus. QJM: An International Journal of Medicine. 1993;86(11):739–742. doi: 10.1093/oxfordjournals.qjmed.a068755.
    1. Zuberi B. F., Akhtar N., Afsar S. Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and non-diabetic subjects. Singapore Medical Journal. 2008;49(2):114–116.
    1. Tschöpe D., Schwippert B., Schettler B., et al. Increased GPIIB/IIIA expression and altered DNA-ploidy pattern in megakaryocytes of diabetic BB-rats. European Journal of Clinical Investigation. 1992;22(9):591–598. doi: 10.1111/j.1365-2362.1992.tb01510.x.
    1. Bavbek N., Kargili A., Kaftan O., Karakurt F., Kosar A., Akcay A. Elevated concentrations of soluble adhesion molecules and large platelets in diabetic patients: are they markers of vascular disease and diabetic nephropathy? Clinical and Applied Thrombosis/Hemostasis. 2016;13(4):391–397. doi: 10.1177/1076029607303615.
    1. Demirtunc R., Duman D., Basar M., Bilgi M., Teomete M., Garip T. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. Journal of Diabetes and its Complications. 2009;23(2):89–94. doi: 10.1016/j.jdiacomp.2008.01.006.
    1. Coban E., Bostan F., Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets. 2009;17(1):67–69. doi: 10.1080/09537100500220729.
    1. Kadić D., Hasić S., Spahić E. Mean platelet volume predicts the glycemic control deterioration in diabetes mellitus type 2 patients. Medicinski Glasnik. 2016;13(1):1–7. doi: 10.17392/843-16.
    1. Afdhal N., McHutchison J., Brown R., et al. Thrombocytopenia associated with chronic liver disease. Journal of Hepatology. 2008;48(6):1000–1007. doi: 10.1016/j.jhep.2008.03.009.
    1. Cho S. Y., Yang J. J., You E., et al. Mean platelet volume/platelet count ratio in hepatocellular carcinoma. Platelets. 2012;24(5):375–377. doi: 10.3109/09537104.2012.701028.
    1. Karagöz B., Sücüllü I., Sayan Ö., et al. Platelet indices in patients with colorectal cancer. Central European Journal of Medicine. 2010;5(3):365–368. doi: 10.2478/s11536-009-0077-7.
    1. Brenner H., Rothenbacher D., Arndt V. Epidemiology of stomach cancer. Methods in Molecular Biology. 2009;472:467–477. doi: 10.1007/978-1-60327-492-0_23.
    1. Kim D. K., Oh S. Y., Kwon H. C., et al. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer. 2009;9(1):p. 155. doi: 10.1186/1471-2407-9-155.
    1. Zhang F., Chen Z., Wang P., Hu X., Gao Y., He J. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients. Tumor Biology. 2016;37(7):9323–9331. doi: 10.1007/s13277-015-4774-3.
    1. Gunduz S., Mutlu H., Uysal M., Coskun H. S., Bozcuk H. Elucidating the correlation between treatment with tyrosine kinase inhibitors and mean platelet volume in patients with metastatic renal cell cancer. Oncology Letters. 2014;8(5):2249–2252. doi: 10.3892/ol.2014.2495.
    1. Safak S., Uslu A. U., Serdal K., Turker T., Soner S., Lutfi A. Association between mean platelet volume levels and inflammation in SLE patients presented with arthritis. African Health Sciences. 2014;14(4):919–924. doi: 10.4314/ahs.v14i4.21.
    1. Butkiewicz A. M., Kemona H., Dymicka-Piekarska V., Matowicka-Karna J., Radziwon P., Lipska A. Platelet count, mean platelet volume and thrombocytopoietic indices in healthy women and men. Thrombosis Research. 2006;118(2):199–204. doi: 10.1016/j.thromres.2005.06.021.
    1. Yazici M., Kaya A., Kaya Y., Albayrak S., Cinemre H., Ozhan H. Lifestyle modification decreases the mean platelet volume in prehypertensive patients. Platelets. 2009;20(1):58–63. doi: 10.1080/09537100802613449.
    1. Eicher J. D., Chami N., Kacprowski T., et al. Platelet-related variants identified by exomechip meta-analysis in 157,293 individuals. The American Journal of Human Genetics. 2016;99(1):40–55. doi: 10.1016/j.ajhg.2016.05.005.
    1. Kunicki T. J., Nugent D. J. The genetics of normal platelet reactivity. Blood. 2010;116(15):2627–2634. doi: 10.1182/blood-2010-04-262048.
    1. Kunicki T. J., Williams S. A., Nugent D. J. Genetic variants that affect platelet function. Current Opinion in Hematology. 2012;19(5):371–379. doi: 10.1097/MOH.0b013e3283567526.
    1. Shameer K., Denny J. C., Ding K., et al. A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects. Human Genetics. 2014;133(1):95–109. doi: 10.1007/s00439-013-1355-7.
    1. Vasudeva K., Munshi A. Genetics of platelet traits in ischaemic stroke: focus on mean platelet volume and platelet count. The International Journal of Neuroscience. 2019;129(5):511–522. doi: 10.1080/00207454.2018.1538991.
    1. Hou J., Liu C., Yao P., et al. Association of adiposity indices with platelet distribution width and mean platelet volume in Chinese adults. PLoS One. 2015;10(6, article e0129677) doi: 10.1371/journal.pone.0129677.
    1. Ijaz S. H., Jamal S. M., Qayyum R. Relationship between thyroid hormone levels and mean platelet count and volume: quantitative assessment. Cureus. 2018;10(10, article e3421) doi: 10.7759/cureus.3421.
    1. Abudesimu A., Liu F., Siti D., et al. An assessment of platelet parameters in different ethnic groups with hypertension subtypes and associated risk factors in Xinjiang, China. Clinical and Experimental Hypertension. 2017;40(6):574–581. doi: 10.1080/10641963.2017.1411494.
    1. Cho S. Y., You E., Lee H., Lee W., Park T. Smoking cession decreases mean platelet volume in healthy Korean populations. Clinical Laboratory. 2014;60 doi: 10.7754/clin.lab.2013.130901.
    1. Biino G., Portas L., Murgia F., et al. A population-based study of an Italian genetic isolate reveals that mean platelet volume is not a risk factor for thrombosis. Thrombosis Research. 2012;129(4):e8–13. doi: 10.1016/j.thromres.2011.11.018.
    1. Santimone I., di Castelnuovo A., de Curtis A., et al. White blood cell count, sex and age are major determinants of heterogeneity of platelet indices in an adult general population: results from the MOLI-SANI project. Haematologica. 2011;96(8):1180–1188. doi: 10.3324/haematol.2011.043042.
    1. Demirin H., Ozhan H., Ucgun T., et al. Normal range of mean platelet volume in healthy subjects: insight from a large epidemiologic study. Thrombosis Research. 2011;128(4):358–360. doi: 10.1016/j.thromres.2011.05.007.
    1. Vasse M., Masure A., Lenormand B. Mean platelet volume is highly correlated to platelet count. Thrombosis Research. 2012;130(3):559–560. doi: 10.1016/j.thromres.2012.04.014.
    1. Klovaite J., Benn M., Yazdanyar S., Nordestgaard B. G. High platelet volume and increased risk of myocardial infarction: 39,531 participants from the general population. Journal of Thrombosis and Haemostasis. 2011;9(1):49–56. doi: 10.1111/j.1538-7836.2010.04110.x.
    1. Lippi G., Meschi T., Borghi L. Mean platelet volume increases with aging in a large population study. Thrombosis Research. 2012;129(4):e159–e160. doi: 10.1016/j.thromres.2011.12.031.
    1. Butkiewicz A. M., Kemona-Chetnik I., Dymicka-Piekarska V., Matowicka-Karna J., Kemona H., Radziwon P. Does smoking affect thrombocytopoiesis and platelet activation in women and men? Advances in Medical Sciences. 2006;51:123–126.
    1. Butkiewicz A. M., Kemona H., Dymicka-Piekarska V., Matowicka-Karna J. Does menopause affect thrombocytopoiesis and platelet activation? Przeglad lekarski. 2006;63(12):1291–1293.
    1. Panova-Noeva M., Schulz A., Hermanns M. I., et al. Sex-specific differences in genetic and nongenetic determinants of mean platelet volume: results from the Gutenberg Health Study. Blood. 2016;127(2):251–259. doi: 10.1182/blood-2015-07-660308.
    1. Bulur S., Albayrak M., Bulur S., et al. Effect of combined oral contraceptive use on platelet volume in women at reproductive age. Clinical and Experimental Obstetrics & Gynecology. 2012;39(3):314–316.
    1. Saleh A. A. A., Ginsburg K. A., Duchon T. A., et al. Hormonal contraception and platelet function. Thrombosis Research. 1995;78(4):363–367. doi: 10.1016/0049-3848(95)91464-V.
    1. Colkesen Y., Coskun I., Muderrisoglu H. The effect of aspirin on mean platelet volume in patients with paroxysmal atrial fibrillation. Platelets. 2012;24(4):263–266. doi: 10.3109/09537104.2012.682106.
    1. Bancroft A. J., Abel E. W., Mclaren M., Belch J. J. Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer. Platelets. 2000;11(7):379–387. doi: 10.1080/09537100020008311.
    1. Giles C. The platelet count and mean platelet volume. British Journal of Haematology. 1981;48(1):31–37.
    1. Park Y., Schoene N., Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets. 2009;13(5-6):301–306. doi: 10.1080/095371002220148332.
    1. Hong K. H., Kim M. J., Lee K. W., Park K. U., Kim H. S., Song J. Platelet count evaluation using three automated haematology analysers compared with the immunoplatelet reference method, and estimation of possible inadequate platelet transfusion. International Journal of Laboratory Hematology. 2009;31(3):298–306. doi: 10.1111/j.1751-553X.2008.01032.x.
    1. Briggs C., Harrison P., Machin S. J. Continuing developments with the automated platelet count. International Journal of Laboratory Hematology. 2007;29(2):77–91. doi: 10.1111/j.1751-553X.2007.00909.x.
    1. Machin S. J., Briggs C. Mean platelet volume: a quick, easy determinant of thrombotic risk? Journal of Thrombosis and Haemostasis. 2010;8(1):146–147. doi: 10.1111/j.1538-7836.2009.03673.x.
    1. Laufer N., Grover N. B., Ben-Sasson S., Freund H. Effects of adenosine diphosphate, colchicine and temperature on size of human platelets. Thrombosis and Haemostasis. 1979;41(3):491–497.
    1. Threatte G. A., Adrados C., Ebbe S., Brecher G. Mean platelet volume: the need for a reference method. American Journal of Clinical Pathology. 1984;81(6):769–772. doi: 10.1093/ajcp/81.6.769.
    1. Lippi U., Cappelletti P., Schinella M., Signori D. Mean platelet volumes: facts or artifacts? American Journal of Clinical Pathology. 1985;84(1):111–113. doi: 10.1093/ajcp/84.1.111.
    1. Barradas M. A., Stansby G., Hamilton G., Mikhailidis D. P. Diminished platelet yield and enhanced platelet aggregability in platelet-rich plasma of peripheral vascular disease patients. International Angiology. 1994;13(3):202–207.
    1. Noris P., Melazzini F., Balduini C. L. New roles for mean platelet volume measurement in the clinical practice? Platelets. 2016;27(7):607–612. doi: 10.1080/09537104.2016.1224828.
    1. Jagroop I. A., Mikhailidis D. P. Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer. Platelets. 2009;12(3):p. 171. doi: 10.1080/09537100120039398.
    1. Latger-Cannard V., Debourgogne A., Montagne K., Plénat F., Lecompte T. Platelet satellitism and lympho-agglutination as presenting finding in marginal zone B-cell lymphoma. European Journal of Haematology. 2009;83(1):81–82. doi: 10.1111/j.1600-0609.2009.01232.x.
    1. Noris P., Balduini C. L. Small red blood cells mimicking platelets. Blood. 2014;123(26):p. 4014. doi: 10.1182/blood-2014-04-569749.
    1. Latger-Cannard V., Hoarau M., Salignac S., Baumgart D., Nurden P., Lecompte T. Mean platelet volume: comparison of three analysers towards standardization of platelet morphological phenotype. International Journal of Laboratory Hematology. 2012;34(3):300–310. doi: 10.1111/j.1751-553X.2011.01396.x.
    1. Pathepchotiwong K., Dhareruchta P., Adirojananon W. Platelet parameter in healthy subjects analyzed by automation analyzer. Thai Journal of Hematology and Transfusion Medicine. 2001;11:93–100.
    1. Noris P., Klersy C., Zecca M., et al. Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 2009;7(12):2131–2136. doi: 10.1111/j.1538-7836.2009.03614.x.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe